Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001144204-12-022163
Filing Date
2012-04-17
Accepted
2012-04-17 12:40:17
Documents
3
Period of Report
2012-04-17

Document Format Files

Seq Description Document Type Size
1 FORM 6-K v309684_6k.htm 6-K 127905
2 GRAPHIC image_001.jpg GRAPHIC 4022
3 GRAPHIC image_002.jpg GRAPHIC 1763
  Complete submission text file 0001144204-12-022163.txt   137174
Mailing Address 85 MEDINAT HAYEHUDIM ST. PITUACH, PO BOX 4033 HERZLIYA L3 46140
Business Address XTL BIOPHARMACEUTICALS LTD C/O ALSTON & BIRD LLP, 90 PARK AVENUE NEW YORK NY 10016 972 9 955 7080
XTL BIOPHARMACEUTICALS LTD (Filer) CIK: 0001023549 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 000-51310 | Film No.: 12763117
SIC: 2834 Pharmaceutical Preparations